Back to Authors

Bui, Yvonne Tran

0000-0002-7414-2461

Mayo Clinic

Mayo Clinic Alix School of Medicine, Rochester, Minnesota, USA.

Citations 1

Evaluating resilience as a predictor of outcomes in lung transplant candidates
Bui, Yvonne , Hathcock, Matthew , Benzo, Roberto P. , Budev, Marie , Chandrashekaran, Satish, Erasmus, D , Levine, Deborah J. , Thompson, Karin L., Johnson, Bradley K. , Jowsey‐Gregoire, Sheila G. , Kennedy, Cassie C. , Bui, Yvonne Tran , Jowsey-Gregoire, Sheila G, Kennedy, Cassie C , Lease, Erika D.

Clinical Transplantation | August 4, 2020 | Volume: 34 | Issue: 10 | Pages: No page available

10.1111/ctr.14056 Get It

AbstractBackgroundResilience represents the capacity to adapt to adversity. Resilience can improve following behavioral interventions. We examined lung transplant candidates’ resilience as a novel predictor using the Connor‐Davidson Resilience Scale (RISC‐10).MethodsWaitlisted candidates at six centers were mailed questionnaires from 9/16/2015 to 10/1/2019. Follow‐up surveys were collected annually and post‐transplant. Outcomes were recorded through February 17, 2020. Primary outcome was pre‐transplant death/delisting. Analyses included t test or chi‐square for group comparisons, Pearson's correlation coefficients for strength of relationships, and Cox proportional‐hazard models to evaluate associations with outcomes, adjusting for age, sex, and mood.ResultsParticipation was 55.3% (N = 199). Baseline RISC‐10 averaged 32.0 ± 5.6 and did not differ by demographics, primary transplant diagnosis, or disease severity markers. RISC‐10 did not correlate to the commonly utilized Psychosocial Assessment of Candidates for Transplant [PACT] or Stanford Integrated Psychosocial Assessment for Transplantation [SIPAT] tools. Scores < 26.3 (representing > 1 standard deviation below population average) occurred in 16% and were associated with pre‐transplant death or delisting, adjusted Hazard Ratio of 2.60 (95% Confidence Interval 1.23‐5.77; P = .01).ConclusionOne in six lung candidates had low resilience, predicting increased pre‐transplant death/delisting. RISC‐10 did not correlate with PACT or SIPAT; resilience may represent a novel risk factor.